Table 1.
No. | Age (years) | Sex | Location | Pathology | Stage (TNM) | IRS-Group | Registered clinical study group | |
---|---|---|---|---|---|---|---|---|
Group non-Cx | 1 | 0.6 | M | Bladder | Embryonal | 2 | III | JRSG |
2 | 4.4 | M | Prostate | Embryonal | 2 | III | JRSG | |
Group Cx | 3 | 0.9 | M | Prostate | Unknown | 3 | III | None |
4 | 2.7 | F | Bladder | Embryonal | 3 | III | None | |
5 | 2.8 | M | Prostate | Embryonal | 3 | III | JRSG |
Abbreviations: IRS: intergroup rhabdomyosarcoma study group; M: male; F: female; JRSG: Japan Rhabdomyosarcoma Study Group.